Introduction Rheumatoid arthritis is an immune disorder that causes joint inflammation and damage, often leading to deformities and disability. Conventional treatments have limitations, but the emergence of antibody drugs offers…
Introduction Janus kinase inhibitors (JAKis) are a class of drugs that differ from biologics in their mechanism of action and are rapidly gaining traction in the field of rheumatology. JAK,…
Introduction Rheumatoid arthritis (RA) is an autoimmune disease that affects multiple joints symmetrically and can also affect other organs. It has a prevalence of around 1% globally and affects women…
Introduction The last few decades have seen major therapeutic advancements in rheumatoid arthritis (RA) therapeutics. New disease-modifying antirheumatic drugs (DMARDs) have created more choices for people, but no therapeutic works…
Introduction Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease characterized by synovial inflammation, bone erosion, and cartilage destruction that leads to joint damage and deformity. Recent advances in pathogenesis…
Abstract Rheumatoid arthritis (RA) is an autoimmune inflammatory disease that mostly affects the synovial joints. It is characterised by chronic inflammation that causes painful swelling and may ultimately lead to…
Introduction Rheumatoid arthritis (RA) is a chronic condition characterised by periods of remission alternated with disease reactivations (ie, flares). Though RA treatment options are rapidly growing, glucocorticoids are still frequently…
Abstract In the treatment of rheumatoid arthritis (RA), Janus kinase inhibitors (jakinibs) represent an emerging class of targeted therapies in addition to biologics. The number of jakinibs has been growing…
Abstract Rheumatoid arthritis (RA) is a joint-related autoimmune disease that is difficult to cure. Most therapeutics act to alleviate the symptoms but not correct the causes of RA. Novel strategies…
Introduction Treatments used for rheumatoid arthritis (RA) are under investigation for their efficacy to prevent RA in at risk groups. It is therefore important to understand treatment preferences of those…
